OTCMKTS:HSDT

Helius Medical Technologies Stock News

Healthcare > Medical - Devices

Buy HSDT

*Your capital is at risk

$1.51

-0.120 (-7.36%)

At Close: Jun 23, 2026

Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should Know

11:17am, Thursday, 07'th Dec 2023

The mean of analysts' price targets for Helius Medical Technologies, Inc. (HSDT) points to a 1249.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, str

Helius Medical Technologies to Present at NobleCon19 Annual Conference

07:47am, Thursday, 30'th Nov 2023

NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuro

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

08:11am, Sunday, 12'th Nov 2023

Helius Medical Technologies, Inc (NASDAQ:HSDT ) Q3 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Michelle Gable Bilski - In-Site Communications, IR Dane Andreeff - Pre

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

05:05pm, Thursday, 02'nd Nov 2023

-- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023 -- -

3 Metaverse Stocks to Invest in for the Internet's Next Evolution

02:34pm, Friday, 20'th Oct 2023

In September, sales at U.S. retailers defied expectations by increasing 0.7%, demonstrating that households possess substantial purchasing power, a crucial factor in sustaining economic growth. A surg

Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference

07:05am, Wednesday, 13'th Sep 2023

-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science behind its effectiveness,

Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?

08:32am, Tuesday, 05'th Sep 2023

Helius Medical Technologies (NASDAQ: HSDT ) stock is rising higher on Tuesday as investors react to the neurotechnology company regaining listing compliance. Helius Medical Technologies says that it

Helius Medical Technologies, Inc. (HSDT) Q2 2023 Earnings Call Transcript

08:44pm, Thursday, 10'th Aug 2023

Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Michelle Bilski - In-Site Communications, IR Dane Andreeff - President

Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates

07:46pm, Thursday, 10'th Aug 2023

Helius Medical Technologies, Inc. (HSDT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.97 per share a year ago.

Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023

04:05pm, Wednesday, 02'nd Aug 2023

NEWTOWN, Pa., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neur

Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest

04:05pm, Wednesday, 14'th Jun 2023

NEWTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuro

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by